Laure Surgers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Laure Surgers has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
B. Carbonne
Université Paris VI – Pierre et Marie Curie, Paris, France
2 shared publicationsE. Bingen
Laboratoire de Microbiologie, AP-HP, Hôpital Robert Debré, Paris, France
2 shared publicationsJ.-L. Meynard
Service des Maladies Infectieuses et Tropicales, AP-HP, Hôpital Saint-Antoine, Paris, France
2 shared publicationsA. Lefort
INSERM, IAME, UMR 1137, Sorbonne Paris Cité, University Paris Diderot, Paris, France
1 shared publication- Alexandre Bleibtreu
Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, 75018 Paris, France
1 shared publication - Charles Burdet
Department of Epidemiology, Biostatistics and Clinical Research, Bichat Hospital, Paris, France
1 shared publication
Latest Publications
- 1 December 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (12) , O1035-O1041
Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses
- 1 December 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (12) , O1035-O1041
Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses
- 21 August 2012
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (1) , 107-113
Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum
The outcome of bacterial bloodstream infections during pregnancy has greatly improved over the last few decades. However, there are no recent data on the characteristics of bacteremia in pregnant women. The aim of this study was to describe clinical and microbiological features of bacteremia and to assess maternal and fetal outcome. This retrospective study was conducted in the obstetrics departments of five teaching hospitals in Paris, France, from 2005 to 2009. The incidence of bacteremia was 0.3%. The most common sources of bacteremia were chorioamnionitis (47%) and the most common pathogen isolated was Escherichia coli. Empirical antimicrobial therapy was inappropriate in 29% of bacteremia cases, mostly (65%) when secondary to infection with an aminopenicillin-resistant microorganism. Bacteremia during pregnancy was associated with a 10% fetal mortality. Bacteremia during pregnancy is a rare occurrence, but it is associated with an unexpectedly poor fetal outcome and a high mortality rate.
- 21 August 2012
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (1) , 107-113
Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum
The outcome of bacterial bloodstream infections during pregnancy has greatly improved over the last few decades. However, there are no recent data on the characteristics of bacteremia in pregnant women. The aim of this study was to describe clinical and microbiological features of bacteremia and to assess maternal and fetal outcome. This retrospective study was conducted in the obstetrics departments of five teaching hospitals in Paris, France, from 2005 to 2009. The incidence of bacteremia was 0.3%. The most common sources of bacteremia were chorioamnionitis (47%) and the most common pathogen isolated was Escherichia coli. Empirical antimicrobial therapy was inappropriate in 29% of bacteremia cases, mostly (65%) when secondary to infection with an aminopenicillin-resistant microorganism. Bacteremia during pregnancy was associated with a 10% fetal mortality. Bacteremia during pregnancy is a rare occurrence, but it is associated with an unexpectedly poor fetal outcome and a high mortality rate.